awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38103514-E1363B9B-8108-4282-848A-F59525DCC5C9
Q38103514-E1363B9B-8108-4282-848A-F59525DCC5C9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38103514-E1363B9B-8108-4282-848A-F59525DCC5C9
Quantifying benefit-risk preferences for medical interventions: an overview of a growing empirical literature.
P2860
Q38103514-E1363B9B-8108-4282-848A-F59525DCC5C9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38103514-E1363B9B-8108-4282-848A-F59525DCC5C9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
635fa5f46d144037ff5df78b0c18391ea2a028ef
P2860
Patients rank toxicity against progression free survival in second-line treatment of advanced renal cell carcinoma.